BioRestorative Therapies, Inc. Share Price Other OTC
Stocks
BRTX
US0906554086
Biotechnology & Medical Research
| Market Cap | 87.9L 76.89L 70.92L 65.5L 1.24Cr 84Cr 1.26Cr 8.47Cr 3.33Cr 41Cr 3.3Cr 3.23Cr 141.98Cr | P/E 2026 * |
-0.7x | P/E 2027 * | -0.85x |
|---|---|---|---|---|---|
| Enterprise Value | 87.9L 76.89L 70.92L 65.5L 1.24Cr 84Cr 1.26Cr 8.47Cr 3.33Cr 41Cr 3.3Cr 3.23Cr 141.98Cr | EV / Sales 2026 * |
6.26x | EV / Sales 2027 * | 3.8x |
| Free-Float |
87.87% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioRestorative Therapies, Inc.
| 1 day | +1.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Lance Alstodt
CEO | Chief Executive Officer | 55 | 16/11/2020 |
Robert Kristal
DFI | Director of Finance/CFO | 59 | 04/11/2021 |
Rory Rumore
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Lance Alstodt
CHM | Chairman | 55 | 16/11/2020 |
David Rosa
BRD | Director/Board Member | 60 | 29/10/2021 |
Mika Grasso
BRD | Director/Board Member | 28 | 12/06/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | +0.25% | - | - | 87.9L | |
| -4.14% | -8.06% | +57.35% | +117.24% | 5.46TCr | |
| +1.84% | -0.66% | +75.79% | +93.87% | 5.49TCr | |
| -2.24% | +3.59% | +19.60% | +466.72% | 2.51TCr | |
| -1.60% | -6.21% | -19.69% | -14.84% | 2.31TCr | |
| +2.43% | +1.06% | +47.70% | -0.11% | 1.99TCr | |
| -3.19% | 0.00% | +33.99% | -26.87% | 1.75TCr | |
| -6.84% | +2.18% | +195.12% | +357.18% | 1.65TCr | |
| -1.05% | +1.16% | +25.08% | +196.28% | 1.42TCr | |
| +8.74% | +3.51% | +53.81% | - | 1.54TCr | |
| Average | -0.50% | -0.28% | +54.31% | +148.68% | 2.68TCr | |
| Weighted average by Cap. | -0.91% | -1.46% | +55.04% | +137.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.05L 12.29L 11.34L 10.47L 19.87L 13Cr 20.2L 1.35Cr 53.19L 6.6Cr 52.75L 51.61L 23Cr | 23.12L 20.23L 18.66L 17.23L 32.7L 22Cr 33.25L 2.23Cr 87.54L 11Cr 86.83L 84.94L 37Cr |
| Net income | -1.35Cr -1.18Cr -1.09Cr -1.01Cr -1.91Cr -128.98Cr -1.94Cr -13Cr -5.12Cr -64Cr -5.08Cr -4.97Cr -218.43Cr | -1.56Cr -1.36Cr -1.26Cr -1.16Cr -2.2Cr -148.39Cr -2.24Cr -15Cr -5.89Cr -73Cr -5.84Cr -5.71Cr -251.3Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
